MedTrace Logo

TXA in the EMS on the Helicopter and the Ambulance

NCT02354885 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-02-03

No results posted yet for this study

Summary

Coagulopathy in trauma increases mortality and morbidity. Early administration of tranexamic acid (TXA) seems to improve survival and outcome. Thus this study evaluates the administration of TXA on scene by the emergency medical services (EMS) or by the crew of a rescue helicopter in multiple trauma patients or isolated traumatic brain injury (TBI). Coagulopathy will be assessed by standard laboratory tests as well as thromboelastometry.

Conditions

Interventions

DRUG

Tranexamic Acid

Coagulation Management / Efficiency

Sponsors & Collaborators

  • Cantonal Hospital of St. Gallen

    collaborator OTHER

  • Luzerner Kantonsspital

    collaborator OTHER

  • University of Zurich

    lead OTHER

Principal Investigators

  • Oliver M. Theusinger, PD Dr med · USZ

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02354885 on ClinicalTrials.gov